Parsippany, New Jersey-based Loretta Itri has built a successful career as an executive at Hoffmann-La Roche, Ortho Biotech, and other pharmaceutical companies. In her current role as the Executive Vice President of Global Health Sciences and Regulatory Affairs at The Medicines Company, Loretta Itri oversees such clinical development divisions as biostatistics. A specialized form of statistics, biostatistics concerns itself with the interpretation of complicated scientific data. Biostatisticians focus on data related to, among other disciplines, public health, clinical medicine, and biology. Biostatistics often involves the careful analysis of data arising from studies involving human subjects. With the potential for a wide variety of results, biostatisticians rely on statistics to navigate and transform the data from such studies into usable information. This can help them uncover the origin of diseases and otherwise overcome various medical challenges. However, biostatistics extends beyond data analysis. By collaborating with other health care professionals, biostatisticians can advance scientific inquiry by playing an instrumental role in the design of clinical trials and other medical experiments.
0 Comments
|
AuthorAs chief medical officer and president of pharmaceutical development at a public biotech company, Dr. Loretta Itri oversaw the worldwide development of a number of important drugs, including Tesetaxel, a novel oral taxane used in the treatment of breast, gastric, and prostate cancer. Archives
October 2019
Categories |